On June 8, the U.S. Food and Drug Administration (FDA) approved Perjeta (pertuzumab), a new anti-HER2 therapy, to treat patients with HER2-positive late-stage breast…
In a draft recommendation statement, the U.S. Preventive Services Task Force (USPSTF) recommends against the use of combined estrogen and progestin for the prevention…
Preschool children of mothers who consumed low to moderate quantities of alcohol during pregnancy had no difference in test performance compared to mothers who…
“Developing & Strengthening Nurse-Physician Relationships: A CEP American White Paper,” released on June 12, details a program to improve nurse-physician relationships in the ED.…
In a draft recommendation statement, the U.S. Preventive Services Task Force (USPSTF) recommends against the use of combined estrogen and progestin for…
“Developing & Strengthening Nurse-Physician Relationships: A CEP American White Paper,” released on June 12, details a program to improve nurse-physician relationships in…